Circularis increases production of proteins, accuracy of diagnostics, and targeting of cancer therapeutics. Our technology discovers, analyzes, and evolves promoters in volumes over 100x the nearest competitor. This allows us to control all information flow within a cell.

Check out this interview with CEO Paul Feldstein

Be Part of the Revolution!

Next program starts Winter 2017. Early applications due July 30th!